PREFACE OF BIOMARKERS IN RECENT ASPECTS OF CANCER: A REVIEW
Tanushree Roy1* and Saikat Ghosh2
1Department of Pharmacology, Gupta College of Technological Sciences, Asansol-713301, West Bengal, India.
2Department of Pharmaceutical Technology, Jadavpur University, Kolkata-700032, West Bengal, India.
ABSTRACT
In recent years, cancer biomarkers provide a great opportunity for
improving the management of cancer patients by enhancing the
efficiency of detection and efficacy of treatment. Biomarkers include a
broad range of biochemical entities, such as nucleic acids, proteins,
sugars, lipids, and small metabolites, cytogenetic and cytokinetic
parameters as well as whole tumor cells found in the body fluid.
Biomarkers used for screening, monitoring, diagnosis and treatment
optimization must have the potential to improve patient outcomes and
reduce costs associated with inappropriate (or suboptimal) therapeutic
regimens. Each biomarker with its relative advantages provides a wide
range of multiple therapeutic alternatives currently available. This
review provides a brief account on various biomarkers that would fill
the gap currently existing between basic research and clinical use of
advanced diagnostics.
Keywords: epigenetic, mTOR, biomarker, antigen, telomerase, PIN.
[Download Article]
[Download Certifiate]